Gland Pharma Limited

Gland Pharma Limited

Gland Pharma Limited has informed the exchanges about a scheduled one-on-one meeting with institutional investor Ambit PMSS, arranged by B&K / 360One. This meeting is slated for June 25, 2026, as a routine engagement with the investment community. The announcement is a procedural disclosure of an investor interaction, with no specific agenda or material information disclosed at this stage. Such meetings are a standard part of investor relations.

Gland Pharma Limited

Gland Pharma Limited has informed the stock exchanges about the submission of a copy of a newspaper publication. The provided announcement primarily contains administrative details, including addresses for BSE and NSE, and mentions a future date of June 19, 2026. However, the specific content or subject matter of the newspaper publication itself is not detailed within this communication. Consequently, investors cannot discern any key financial figures, decisions, or their implications from this update alone. This appears to be an administrative compliance notification rather than a disclosure of substantive news.